PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Author: Mefford, Matthew T. MS; Rosenson, Robert S. MD; Cushman, Mary MD; Farkouh, Michael E. MD, MSc; McClure, Leslie A. PhD; Wadley, Virginia G. PhD; Irvin, Marguerite R. PhD; Bittner, Vera MD, MSPH; Safford, Monika M. MD; Somaratne, Ransi MD; Monda, Keri L. PhD; Muntner, Paul PhD; Levitan, Emily B. ScD

Page: 1260-1269

http://ift.tt/2ICY0t8